Bionyra Pharma
Developing next-generation biologics for severe immunological and inflammatory diseases
$165MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Developing next-generation biologics for severe immunological and inflammatory diseases
Generates molecular data for drug development
Pitching Vives Partners? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room